Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) will release earnings results for the first quarter, after the closing bell on Monday, Nov. 3.Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.58 per share, up from$4.38 per share in the year-ago period. The consensus estimate for Vertex Pharmaceuticals' quarterly revenue is $3.06 billion, compared to$2.77 billion a year earlier, according to data from Benzinga Pro.On Aug. 4, Vertex Pharmaceuticals posted better-th ...